IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Interest Paid (2025 - 2026)

Updated

IRulya Therapeutics (IRLA) recorded Interest Paid of $29,000 in Q1 2026, down 45.3% from $53,000 a year earlier and down 50.0% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Interest Paid (2025 - 2026) Analysis & Trends

For FY2025, IRulya Therapeutics reported Interest Paid of $234,000.

  • Per Business Quant, the preceding three quarters came in at $58,000 (Q4 2025), $59,000 (Q3 2025) and $64,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 283.00 Mn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 29,000.00
Dec 31, 2025 58,000.00
Sep 30, 2025 59,000.00
Jun 30, 2025 64,000.00
Mar 31, 2025 53,000.00
API Access

IRulya Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=IRLA&period=max&api_key=YOUR_API_KEY